Methylene blue for management of Ifosfamide-induced encephalopathy (2006)

Peer-Reviewed Study · Patel PN · January 3, 2006

Patel PN, 2006-01-03: Review of methylene blue for ifosfamide-induced encephalopathy concluding that only case reports and one chart review exist and no controlled trial supports the practice. It records the state of the evidence for one of the most common non-approved uses.

Several case reports and one retrospective chart review described the use of methylene blue for ifosfamide-induced encephalopathy, but no controlled clinical trials were found.

Patel PN, 2006-01-03: Review of methylene blue for ifosfamide-induced encephalopathy concluding that only case reports and one chart review exist and no controlled trial supports the practice. It records the state of the evidence for one of the most common non-approved uses. Study type: review.